PHAS

PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS

Overview Fund Activity
Delisted

PHAS was delisted on the 2nd of November, 2022.

Back to rankings

61 hedge funds and large institutions have $95.8M invested in PhaseBio Pharmaceuticals, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 23 increasing their positions, 15 reducing their positions, and 6 closing their positions.

Holders
61
Holders Change
+6
Holders Change %
+10.91%
% of All Funds
1.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
23
Reduced
15
Closed
6
Calls
$97K
Puts
$162K
Net Calls
-$65K
Net Calls Change
-$139K

Top Buyers

1
CS
1
Candriam SCA
Luxembourg
$3.36M
2
EP
2
Eversept Partners
New York
$933K
3
CCM
3
CAAS Capital Management
New York
$818K
4
Marshall Wace
4
Marshall Wace
United Kingdom
$681K
5
O
5
OrbiMed
New York
$551K

Top Sellers

1
ECM
1
Endurant Capital Management
California
$3.52M
2
Wellington Management Group
2
Wellington Management Group
Massachusetts
$12.5M
3
GCP
3
GSA Capital Partners
United Kingdom
$0
4
TEE
4
Tibra Equities Europe
United Kingdom
$0
5
E
5
Ergoteles
New York
$34K
Name Market Value Shares Shares
Change 		Shares
Change %
NMC
1
NEA Management Company
Maryland
$20.7M 6,643,704 – –
APM
2
Avidity Partners Management
Texas
$13.7M 4,405,000 +90,000 +2%
Wellington Management Group
3
Wellington Management Group
Massachusetts
$12.5M 4,024,658 -515,239 -11%
RCM
4
RA Capital Management
Massachusetts
$8.86M 2,850,000 – –
Vanguard Group
5
Vanguard Group
Pennsylvania
$5.83M 1,874,573 +5,909 +0.3%
RSCM
6
Rock Springs Capital Management
Maryland
$5.73M 1,843,764 – –
JJ
7
Johnson & Johnson
New Jersey
$5M 1,607,044 +1,607,044 New
ECM
8
Endurant Capital Management
California
$3.52M 1,132,523 -997,186 -47%
CS
9
Candriam SCA
Luxembourg
$3.36M 1,081,258 +461,824 +75%
ACM
10
Altium Capital Management
New York
$2.41M 775,000 – –
DCM
11
DAFNA Capital Management
California
$1.88M 603,042 – –
BlackRock
12
BlackRock
New York
$1.62M 519,359 +32,335 +7%
EP
13
Eversept Partners
New York
$933K 300,000 +300,000 New
Millennium Management
14
Millennium Management
New York
$932K 299,816 +92,273 +44%
Stifel Financial
15
Stifel Financial
Missouri
$911K 292,840 +30,147 +11%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$872K 280,589 +84,729 +43%
CCM
17
CAAS Capital Management
New York
$818K 263,172 +263,172 New
PTP
18
Platform Technology Partners
New York
$713K 229,223 -150 -0.1%
Marshall Wace
19
Marshall Wace
United Kingdom
$681K 218,877 +218,877 New
BCM
20
Bridgeway Capital Management
Texas
$639K 205,600 +117,000 +132%
Susquehanna International Group
21
Susquehanna International Group
Pennsylvania
$561K 180,359 +123,075 +215%
O
22
OrbiMed
New York
$551K 177,113 +177,113 New
Morgan Stanley
23
Morgan Stanley
New York
$464K 149,162 +20,081 +16%
Renaissance Technologies
24
Renaissance Technologies
New York
$313K 100,566 +100,566 New
OIA
25
OneDigital Investment Advisors
Kansas
$274K 88,150 +35,700 +68%
1
2 3